Source: Eur Respir J 2016; 47: 967-977
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kolahian Saeed, Öz Hasan Halit, Zhou Benyuan, Griessinger Christoph M., Rieber Nikolaus, Hartl Dominik. The emerging role of myeloid-derived suppressor cells in lung diseases. Eur Respir J 2016; 47: 967-977

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory role of myeloid-derived suppressor cells in asthma in vivo Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017 Galectin-9 attenuates acute lung injury in mice by inducing myeloid-derived suppressor cells Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF Source: ERS Lung Science Conference 2016 Year: 2016 Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Myeloid-derived suppressor cells in the blood of COVID-19 patients Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 LSC Abstract – Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis Source: Eur Respir J 2016; 48: 1171-1183 Year: 2016 T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease Source: Annual Congress 2011 - T-cell subsets Year: 2011 The role of NHE-1 on multidrug-resistance mechanisms of human small cell lung cancer cells Source: Eur Respir J 2007; 30: Suppl. 51, 537s Year: 2007 Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 T-regulatory cells in COPD or tumour environment Source: Eur Respir J 2009; 34: 284 Year: 2009 Angiogenic T cells in interstitial lung diseases Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Regulatory T, B cells and inflammation: Do they play an important role in lung cancer? Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Proof of an immunosuppressive phenotype of dendritic cells in lung cancer microenvironment Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010